RUNX1 and acute myeloid leukemia: Taken together, as summarized in Figure 7I, our study highlights how specific oncogenic transcription factors differentially program the epigenetic landscape in two types of AML with RUNX1 translocations but share the feature that they are dependent on the expression of the fusion protein and the suppression of C/EBPα to inhibit differentiation.